| AGEs | advanced glycation end products |
| AP-1 | activator protein 1 |
| APCs | antigen presenting cells |
| CAP | cellulose acetate phthalate |
| CD | Crohn disease |
| COX-2 | cyclooxygenase-2 |
| CRC | colorectal cancer |
| DN | diabetic nephropathy |
| DR | diabetic retinopathy |
| DSS | dextran sulfate sodium |
| GI | gastrointestinal |
| GM | gut microbiota |
| GRAS | generally recognized as safe |
| HPMCP | hydroxyl propyl methylcellulose phthalate |
| HSPs | heat shock proteins |
| IBD | inflammatory bowel diseases |
| IL6 | interleukin 6 |
| IS | indoxyl sulfate |
| LPS | lipopolysaccharide |
| MAMP | microbe-associated molecular pattern |
| VEGF | vascular endothelial growth factor |
| NF-kB | nuclear factor kappa-light-chain-enhancer of activated B cells |
| PC | p-cresol |
| PCS | p-cresyl sulfate |
| PG | peptidoglycan |
| PYY | peptide tyrosine-tyrosine |
| SCFAs | short-chain fatty acids |
| TMAO | trimethylamine-N-oxide |
| TNF-α | tumor necrosis factor-alpha |
| TOPK | T-LAK cell-originated protein kinase |
| TLRs | toll-like receptors |
| UC | ulcerative colitis |